Table 1.
No. participants | % | |
Demographics | (n = 1767) | |
Age (years) | ||
< 35 | 120 | 6.8 |
35–44 | 450 | 25.5 |
45–54 | 453 | 25.7 |
55–64 | 454 | 25.8 |
65+ | 285 | 16.2 |
Sex | ||
Male | 807 | 45.7 |
Female | 954 | 54.0 |
Race | ||
White | 1444 | 82.4 |
Black | 54 | 3.1 |
Hispanic | 52 | 3.0 |
Asian | 138 | 7.9 |
Other | 26 | 1.5 |
Education | ||
PhD | 1218 | 69.4 |
MD | 174 | 9.9 |
MD, PhD | 64 | 3.6 |
MD, Masters | 219 | 12.5 |
Masters | 62 | 3.5 |
Region | ||
Northeast | 485 | 27.5 |
Midwest | 360 | 20.4 |
South | 497 | 28.2 |
West | 365 | 20.7 |
International | 35 | 2.0 |
Years in health research | ||
< 1 to 10 | 332 | 18.8 |
11 to 20 | 655 | 37.1 |
21 to 30 | 410 | 23.2 |
31 or more | 369 | 20.9 |
Institution typea | ||
Academic | 1544 | 87.4 |
Public | 337 | 19.1 |
Non-profit | 248 | 14.0 |
Private | 60 | 3.4 |
Other | 9 | 0.5 |
Funding typea | ||
Public | 1689 | 95.6 |
Foundation | 275 | 15.6 |
Private | 103 | 5.8 |
Other | 83 | 4.7 |
Clinical and Translational Science Award (CTSA) | ||
Yes | 1084 | 61.3 |
No | 383 | 21.7 |
Methods used* | ||
Implementation science | 223 | 12.7 |
RCTs | 759 | 43.0 |
Cohort studies | 518 | 29.4 |
Epidemiology | 419 | 23.8 |
Population studies | 272 | 15.5 |
Statistics | 308 | 17.5 |
Qualitative | 315 | 17.9 |
Other | 1025 | 58.3 |
RCTs randomized controlled trials
aRespondents could select multiple responses therefore values can sum to greater than 100%